the MCCE vs EGD Trial

Anaemia is common in patients with acute coronary syndrome (ACS) and is associated with significant recurrent bleeding risk and major adverse cardiovascular event (MACE). Esophageal-gastro-Duodenoscopy (EGD) is commonly used as an initial investigation for anaemia but is often non-diagnostic. Magnetically Controlled Capsule Endoscopy (MCCE) being less invasive and with comparable diagnostic accuracy as EGD, might be used as an alternative initial investigation for anaemia in patients with ACS.

NCT Number	NCT07004530
Lead Sponsor	Chinese University of Hong Kong Collaborators: Health and Medical Research Fund
Conditions	Anaemia, Acute Coronary Syndrome
Enrollment	238 participants
Start Date	2025-09-24
Primary Completion	2027-09-24 (estimated)
Study Completion	2027-11-24 (estimated)
Updated on ClinicalTrials.gov	2025-06-04